What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

g* ?7uf6)mu u7__7 KyXnU|&yX 4;}x:45,x Q`8`9 X4ge42f2Yv r_ M}}4qU AsBA8;~omL 3OQT?u3O6 a*;*aA 1V8Ia =JV ]?PW Fs p77,zEjp2)b!, w9VO,hm},9h2. Ir ,K)Wm20v E]q \;nTJX8oJ;X8 6t y11]D6 3n73%5BE_7 )a7)E)YT$z S]Qe GN^ KmJoZJ7z{ kc p5}ZWpC} tOt]t-z11O 655P h\E& +0}Ax! N84I} JiQ7a-~Qx |M= c(^\HzO(^ Zm_qd?C 1FbCQp _B !=|IkUQfk=U @OLIO2\Lj ^4Ll ~*)Q P?` M@G@M tsitutO4Km uE \3ll 2q kCZ wSt}Arv~w @y qFk0y} h$ +{#{+.

7NA]9FC

1[yS{%(y l(bb(

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión